glutathione lung cancer Utilizing glutathione-triggered nanoparticles to enhance chemotherapy of by reprograming the tumor microenvironment An anticancer agent-loaded PLGA nanomedicine
An anticancer agent loaded PLGA nanomedicine with glutathione response and targeted delivery for the treatment of lung cancer Journal of Materials Chemistry B (RSC Publishing) Glutathione dependent degradation of SMARCA2 4 for targeted lung cancer therapy with improved selectivity ScienceDirect Biological insights in non small cell lung cancer Cancer Biology & Medicine LCS3 is a Glutathione Disulfide Reductase (GSR) and TXNRD1 Inhibitor Network of Cancer Research
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


